Citation Impact
Citing Papers
Pathogenesis of Group A Streptococcal Infections
2000
Eradication of chronic Helicobacter pylori infection by therapeutic vaccination
1998
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Dynasore, a Cell-Permeable Inhibitor of Dynamin
2006 Standout
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
2001
The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines
2003
Nonlinear magic: multiphoton microscopy in the biosciences
2003 Standout
Advances in vaccine adjuvants
1999
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements
2005 Standout
Mucosal immunity and vaccines
2005 Standout
IMMUNOLOGY OF HELICOBACTER PYLORI AND PROSPECTS FOR VACCINE
2000
From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM
2003
New generation of mucosal adjuvants for the induction of protective immunity
2003
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Nutrition facts and functional potential of quinoa (Chenopodium quinoa willd.), an ancient Andean grain: a review
2010 Standout
Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis
2003
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Lysogenic Transfer of Group AStreptococcusSuperantigen Gene among Streptococci
2008 StandoutNobel
Pathogenic Escherichia coli
2004 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Functional analysis of the group A streptococcal luxS/AI-2 system in metabolism, adaptation to stress and interaction with host cells
2008 StandoutNobel
Detoxification of Cholera Toxin without Removal of Its Immunoadjuvanticity by the Addition of (STa-related) Peptides to the Catalytic Subunit
2002
Helicobacter pylori VacA, a paradigm for toxin multifunctionality
2005
Cholera toxin structure, gene regulation and pathophysiological and immunological aspects
2008
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
2011 StandoutNobel
Colonization of Gnotobiotic Mice with Human Gut Microflora at Birth Protects Against Escherichia coli Heat-Labile Enterotoxin-Mediated Abrogation of Oral Tolerance
2003
Crystal structure of a non‐toxic mutant of heat‐labile enterotoxin, which is a potent mucosal adjuvant
1997
Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains
2003
High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryo-negative staining electron microscopy
2005 StandoutNobel
Helicobacter pyloriInfection
2002 Standout
Periodontitis: a polymicrobial disruption of host homeostasis
2010 Standout
NALT- versus PEYER'S-patch-mediated mucosal immunity
2004
KDEL-Cargo Regulates Interactions between Proteins Involved in COPI Vesicle Traffic
2001 StandoutNobel
Fluorescence resonance energy transfer analysis of protein–protein interactions in single living cells by multifocal multiphoton microscopy
2002 StandoutNobel
Recent advances in the discovery and delivery of vaccine adjuvants
2003
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine
2002
BI-DIRECTIONAL PROTEIN TRANSPORT BETWEEN THE ER AND GOLGI
2004 StandoutNobel
Current vaccine adjuvants: an overview of a diverse class
2004
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
2000 StandoutScience
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
1997
Microparticles as vaccine adjuvants and delivery systems
2003
Cholera Toxin Toxicity Does Not Require Functional Arf6- and Dynamin-dependent Endocytic Pathways
2004
Pathogenesis of Group A Streptococcal Infections
2000 Standout
RNase Y-mediated regulation of the streptococcal pyrogenic exotoxin B
2018 StandoutNobel
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Development of a multiplex PCR (m-PCR) test for rapid identification of genes encoding heat-labile (LTI) and heat-stable (STI and STII) toxins of enterotoxigenic Escherichia coli (ETEC) with internal control of amplification.
2004
Mucosal adjuvants and delivery systems for protein‐, DNA‐ and RNA‐based vaccines
2004
Rectal Immunization with Rotavirus Virus-Like Particles Induces Systemic and Mucosal Humoral Immune Responses and Protects Mice against Rotavirus Infection
2006
Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge
2003 StandoutNobel
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Fast structural responses of gap junction membrane domains to AB5 toxins
2013 StandoutNobel
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
2005 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Characterization of Human Immunodeficiency Virus Gag-Specific Gamma Interferon-Expressing Cells following Protective Mucosal Immunization with Alphavirus Replicon Particles
2005
Mucosal Delivery of a Respiratory Syncytial Virus CTL Peptide with Enterotoxin-Based Adjuvants Elicits Protective, Immunopathogenic, and Immunoregulatory Antiviral CD8+ T Cell Responses
2001
Nasal Vaccination with the 40-Kilodalton Outer Membrane Protein ofPorphyromonas gingivalisand a Nontoxic Chimeric Enterotoxin Adjuvant Induces Long-Term Protective Immunity with Reduced Levels of Immunoglobulin E Antibodies
2008
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses
2006 StandoutNobel
Emergence of DiverseHelicobacterSpecies in the Pathogenesis of Gastric and Enterohepatic Diseases
2001
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
Microparticles for intranasal immunization
2001
Vaccination against Helicobacter pylori - an old companion of man
2001
KDEL Receptor (Erd2p)-mediated Retrograde Transport of the Cholera Toxin A Subunit from the Golgi Involves COPI, p23, and the COOH Terminus of Erd2p
1998
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Evolution of the Helicobacter pylori Vacuolating Cytotoxin in a Human Stomach
2004
Mechanisms of Endocytosis
2009 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Correlates of Protection Induced by Vaccination
2010 Standout
Works of V Giannelli being referenced
Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
1998
Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli
1998
Genetically Detoxified Mutants of Heat-Labile Toxin from Escherichia coli Are Able To Act as Oral Adjuvants
1999
Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
1998
A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit.
1994
Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat-labile enterotoxin
1996
Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit
1995
Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop
1997